Last price paid | 0.20 | |
Change | -4.76% [ -0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 28.05.2024 17:20 |
Fixing | 20.12.2024 |
Settlement date | 24.11.2023 |
Last trading | 20.12.2024 |
Final fixing | 20.12.2024 |
Currency redemption | CHF |
Perf. since issue | n.a. |
Year to date (YTD) | -44.44% |
1 month | +42.86% |
3 months | +5.26% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.32 |
Underlying price on issue | 238.03 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281043245 |
Symbol | ROG2VZ |
Security | 128104324 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | 06.01.2025 |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Strike | 240.00 |
C/P type | call |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | American |
Delivery of securities | On Demand |
Minimum execution | 50 |
Value day | 17.11.2023 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
Moneyness | out-of-the-money |
Leverage | n.a. |
Delta | n.a. |
Gamma | n.a. |
Theta | n.a. |
Rho | n.a. |
Vega | n.a. |
Fair value | n.a. |
Intrinsic value | n.a. |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Warrant (2100) |
Name | Price |
---|---|
Swiss Re | 113.05 |
Givaudan | 4'235.00 |
ABB Ltd | 49.70 |
ZURICH INSURANCE | 469.50 |
ROCHE GS | 228.80 |
Name | Price |
---|---|
Lonza Group | 485.20 |
UBS | 27.94 |
Partners Group Ho... | 1'193.50 |
Alcon AG | 80.22 |
Holcim | 79.16 |